NuCana stock price forecast: rangebound days expected as NCNA holds steady near resistance

Traders Union
All News
Financial News
NuCana trades flat today at $3.70

Highlights

NuCana appointed Theresa Bruce as Chief Operating Officer effective January 1, 2026, strengthening its executive team amid pipeline expansion.
Clinical data showed a patient achieved a complete metabolic response to NUC-7738 in PD-1 inhibitor-resistant metastatic melanoma, demonstrating promising efficacy.
NuCana extended its expected cash runway into 2029, secured a composition of matter patent for NUC-7738 in China, and remains Nasdaq compliant.

Pipeline advances and fresh leadership as cash position strengthens

NuCana appointed Theresa Bruce as Chief Operating Officer, effective January 1, 2026, to reinforce its executive team as it moves forward with an expanding clinical pipeline. Key developments include promising clinical results for NUC-7738 in PD-1 inhibitor-resistant metastatic melanoma, a patient achieving a complete metabolic response, and the granting of a composition of matter patent for NUC-7738 by the Chinese intellectual property authority. The company also reported an expected cash runway into 2029 and confirmed its compliance with Nasdaq listing requirements.

Momentum divergence as bullish pressures test technical resistance

Momentum signals on the daily chart are mixed. The MACD indicates a strong sell, while the ADX reflects weak, non-directional momentum. The RSI stands at a neutral-to-bullish 50.43, the Stochastic RSI is overbought, and the CCI is neutral. Bull/Bear Power shows notable buyer strength intraday. NCNA’s daily performance is flat (0.00% change), with the price holding near the high end of today’s range ($3.50 – $3.74), reflecting mild strength post-open amid low volatility. Divergence among momentum indicators suggests uncertainty, but with a slight tilt toward buyer pressure. Immediate dynamic support is provided by the Ichimoku Kijun at $3.86, with resistance seen at the MA-50 ($3.76).

Downside bias prevails as volatility outlook signals rangebound trade

Over the next week, NCNA is expected to trade within a typical volatility band of $3.58 to $3.71. The probability of a price increase is very low (less than 20%), so further downside remains more likely. The baseline scenario points to consolidation in a tight sideways range. A break above $3.76 resistance could trigger further short covering, while a move below $3.58 would expose the stock to additional downside per longer-term indicators.

Anton Kharitonov, expert at Traders Union, sees NuCana’s recent news and cash runway as positive, but the stock’s technicals remain weak overall. He highlights that buyer strength intraday is offset by mixed momentum signals and resistance at $3.76. Kharitonov remains cautious given low upside probability and sustained long-term downside. "My base case is sideways action within $3.58 – $3.71, and I stay defensive unless price reclaims the $3.76 level decisively."

No asset information was provided in the text for analysis.

Source of Data: NCNA Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.